www.fdanews.com/articles/137999-merck-submits-application-to-extend-indication-of-ms-drug-rebif-in-europe

Merck Submits Application to Extend Indication of MS Drug Rebif in Europe

June 29, 2011

German pharmaceutical and chemicals company Merck KGaA said it has submitted an application to the EMA to extend indication of its multiple sclerosis or MS drug Rebif.
RTT News